International conference on protein stabilityThe gap between industry and administration
This international conference will take place on May 13-14, 2025, in Södertälje, Sweden, bringing together experts from academia, industry, and regulatory bodies. Hosted at Södertälje Science Park, this event will focus on the challenges and advancements in the real-world handling of protein drugs, addressing critical stability issues and mitigation strategies.
Objective
The objective of this symposium/conference is to create an arena for discussions on the recent research and industrial interest in the reality and impact of in-use handling of protein medicines. Real-life handling, important stress factors, simulation, mitigations as well as formulation and education will be covered. The vision is to bring together the different stakeholder groups involved and affected; patients, pharmacists, academic and industrial researchers.
For contact, registration and more information about the conference, please visit the website.
About RealHOPE
The RealHOPE (Real-world handling of protein drugs – Exploration, evaluation and education) project is a joint collaboration by a consortium of 26 partners consisting of pharmaceutical and medical device companies, instrument- and app developers and logistics companies together with universities, institutes, hospital pharmacies, pharmacists and a patient organization from 6 European countries and US. Funded by EU and EFPIA partners and coordinated by RISE Research Institutes of Sweden, with Sanofi as a tech lead, the year project will be active until June 2025.
The RealHOPE consortium covers in-use aspects of protein drug stability, investigating and recognising the critical steps where stability can be compromised. With the common goal to support a safe and efficient use of these medications for patients, whose life often depend on them, RealHOPE have developed concrete and practical recommendations and tools for simulation of real-life events, explored mitigation of critical handling steps, and developed educational material to ensure careful handling by healthcare and pharmacy staff as well as patients. From this, recommendations and guidelines will result that have an immediate impact on drug development, distribution, and handling.
The RealHOPE project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement N° 101007939 (RealHOPE). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Call for papers
The abstract should be prepared using Microsoft Word as half page (A4) typed in Times New Roman, font size 12.
Deadline for abstract submission: 05 March 2025.
Date and venue
The 13-14th of May
Södertälje Science Park
Kvarnbergagatan 12
151 36 Södertälje
Sweden
Organizers
